Fiche société
Hope Biosciences Research Foundation
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications2liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| HB-adMSCsThis individual patient expanded access IND is requested for a patient diagnosed with LMNA-related congenital muscular dystrophy (L-CMD). In this expanded access, the patient will receive the investigational product through 14 intravenous infusions, followed by Follow-Up visit and an End of Study. | Myopathies | À vérifier | À vérifier | United States | À vérifier |
| HB-adMSCsThis individual patient expanded access IND is requested for a patient diagnosed with LMNA-related congenital muscular dystrophy (L-CMD). In this expanded access, the patient will receive the investigational product through 14 intravenous infusions, followed by Follow-Up visit and an End of Study. | Myopathies | À vérifier | À vérifier | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| HB-adMSCs | Myopathies | À vérifier | NCT05154851 | HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy. | NO_LONGER_AVAILABLE |
Publications
2| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| HB-adMSCs | Autologous adipose-derived mesenchymal stromal cells for chronic traumatic brain injury. | Brain : a journal of neurology | ||
| HB-adMSCs | Evaluation of Multiple Intravenous Infusions of Autologous Adipose-Derived Mesenchymal Stem Cells in Parkinson's Disease: A Randomized, Double-Blind Clinical Trial. | Parkinson's disease |